Billiontoone Inc (BLLN) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Billiontoone Inc   (NASDAQ: BLLN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Billiontoone Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Billiontoone Inc in the third quarter 2026?
Billiontoone Inc achieved a return on average equity (ROE) of 9.46 % in its third quarter 2026, this is above BLLN's average return on equity of 0%.
Billiontoone Inc shareholder's equity over the 12 months ending in its third quarter 2026 are valued at $522 million

ROE fell compared to the second quarter 2026, despite the net income growth of 115.93% from the second quarter 2026.

Within the Medical Laboratories industry Billiontoone Inc achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the second quarter 2026 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change 1054.01 % - -95.67 % -98.52 % -
Net Income (TTM) in Millions 49 34 25 423 821
Return On Equity (TTM) 9.46 % 10.45 % 20.39 % - -
BLLN's Total Ranking # # # # #
Equity (TTM) in Millions 567 537 506 480 -240
Seq. Equity Change 5.54 % 6.17 % 5.31 % - -
Seq. Net Income Change 115.93 % -55.18 % 200.65 % 296.62 % -

Back to BLLN Management Effectiveness >> BLLN's 5 Years Annual ROE >> Compare BLLN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





BLLN Annual Return On Equity (Dec 31 2025)
2025



Total Equity in Millions 480 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions 3 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 0.61 % - - - -

Back to BLLN Management Effectiveness >> BLLN's 5 Years Annual ROE >> Compare BLLN ROE to its Competitors




Annual Roe Comment
In 2025 ROE fell to 0.61 %, despite net income growth.


More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BLLN's' Return on Equity at Yahoo Finance
BLLN's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BLLN's Competitors
Subscribers only: Roe for Billiontoone Inc 's Suppliers
Subscribers only: Return On Equity for BLLN's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE
Pacs Group Inc   25.65 %
Standard Biotools Inc   25.58 %
Resmed Inc   25.50 %
Bioventus Inc   24.60 %
Encompass Health Corporation  24.08 %
Iradimed Corporation  23.90 %
Corcept Therapeutics Inc  22.88 %
Msa Safety Inc  21.79 %
Lantheus Holdings Inc   21.72 %
Iqvia Holdings Inc   21.40 %
Denali Therapeutics Inc   21.40 %
West Pharmaceutical Services Inc   21.08 %
Brightspring Health Services Inc   20.31 %
Healthcare Services Group Inc   20.22 %
Vertex Pharmaceuticals Inc  20.08 %
Ge Healthcare Technologies Inc   20.04 %
Neurocrine Biosciences Inc   19.74 %
Ani Pharmaceuticals Inc  19.70 %
Johnson and Johnson  19.55 %
Pediatrix Medical Group Inc   17.28 %
Kiniksa Pharmaceuticals International Plc  17.27 %
Krystal Biotech Inc   17.02 %
Intuitive Surgical Inc   16.99 %
Ensign Group Inc  16.62 %
Lemaitre Vascular Inc   15.81 %
Stryker Corp  15.61 %
Quest Diagnostics Inc  15.22 %
Regeneron Pharmaceuticals Inc   15.07 %
Bio rad Laboratories Inc   14.07 %
Boston Scientific Corporation  13.75 %

Date modified: 2026-11-06T13:07:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.